Skip to main content
icon for CDC issues Level 4 warning by December 31?

CDC issues Level 4 warning by December 31?

icon for CDC issues Level 4 warning by December 31?

CDC issues Level 4 warning by December 31?

dic 31

dic 31

14% probabilidad
Polymarket

$71,968 Vol.

14% probabilidad
Polymarket

$71,968 Vol.

This market will resolve to "Yes" if the CDC issues a Level 4 (“Avoid All Travel”) Travel Health Notice for any disease by December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No". A Level 4 notice listed for any amount of time during this market’s timeframe will suffice for a "Yes" resolution. The primary resolution source for this market will be the CDC’s official Travel Health Notices page (https://wwwnc.cdc.gov/travel/notices); however, a consensus of credible reporting will also be used.**No Level 4 CDC Travel Health Notice appears imminent by year-end, supporting the 75% market-implied probability.** CDC Level 4 notices, which advise avoiding all travel due to extreme health risks with no effective precautions, remain unused as of mid-June 2026. Current notices top out at Level 2 for circulating poliovirus (updated March 2026 to include Laos and Namibia) and select Level 1 alerts for dengue, chikungunya, hepatitis A, and global measles. These reflect ongoing but contained transmission patterns monitored by CDC surveillance, without the uncontrolled outbreaks or novel pathogens that historically trigger Level 4 status, such as peak COVID-19 surges. No recent model runs, case thresholds, or official CDC/NOAA-style escalations point to conditions that would meet Level 4 criteria—extreme risk without mitigation options—before December 31. Traders appear to weigh the low baseline likelihood of rapid escalation against routine seasonal and endemic activity, with upcoming surveillance updates unlikely to shift this assessment absent a major emergence.

This market will resolve to "Yes" if the CDC issues a Level 4 (“Avoid All Travel”) Travel Health Notice for any disease by December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".

A Level 4 notice listed for any amount of time during this market’s timeframe will suffice for a "Yes" resolution.

The primary resolution source for this market will be the CDC’s official Travel Health Notices page (https://wwwnc.cdc.gov/travel/notices); however, a consensus of credible reporting will also be used.
Volumen
$71,968
Fecha de finalización
31 dic 2026
Mercado abierto
Jan 19, 2026, 3:15 PM ET
This market will resolve to "Yes" if the CDC issues a Level 4 (“Avoid All Travel”) Travel Health Notice for any disease by December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No". A Level 4 notice listed for any amount of time during this market’s timeframe will suffice for a "Yes" resolution. The primary resolution source for this market will be the CDC’s official Travel Health Notices page (https://wwwnc.cdc.gov/travel/notices); however, a consensus of credible reporting will also be used.
This market will resolve to "Yes" if the CDC issues a Level 4 (“Avoid All Travel”) Travel Health Notice for any disease by December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No". A Level 4 notice listed for any amount of time during this market’s timeframe will suffice for a "Yes" resolution. The primary resolution source for this market will be the CDC’s official Travel Health Notices page (https://wwwnc.cdc.gov/travel/notices); however, a consensus of credible reporting will also be used.**No Level 4 CDC Travel Health Notice appears imminent by year-end, supporting the 75% market-implied probability.** CDC Level 4 notices, which advise avoiding all travel due to extreme health risks with no effective precautions, remain unused as of mid-June 2026. Current notices top out at Level 2 for circulating poliovirus (updated March 2026 to include Laos and Namibia) and select Level 1 alerts for dengue, chikungunya, hepatitis A, and global measles. These reflect ongoing but contained transmission patterns monitored by CDC surveillance, without the uncontrolled outbreaks or novel pathogens that historically trigger Level 4 status, such as peak COVID-19 surges. No recent model runs, case thresholds, or official CDC/NOAA-style escalations point to conditions that would meet Level 4 criteria—extreme risk without mitigation options—before December 31. Traders appear to weigh the low baseline likelihood of rapid escalation against routine seasonal and endemic activity, with upcoming surveillance updates unlikely to shift this assessment absent a major emergence.

This market will resolve to "Yes" if the CDC issues a Level 4 (“Avoid All Travel”) Travel Health Notice for any disease by December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".

A Level 4 notice listed for any amount of time during this market’s timeframe will suffice for a "Yes" resolution.

The primary resolution source for this market will be the CDC’s official Travel Health Notices page (https://wwwnc.cdc.gov/travel/notices); however, a consensus of credible reporting will also be used.
Volumen
$71,968
Fecha de finalización
31 dic 2026
Mercado abierto
Jan 19, 2026, 3:15 PM ET
This market will resolve to "Yes" if the CDC issues a Level 4 (“Avoid All Travel”) Travel Health Notice for any disease by December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No". A Level 4 notice listed for any amount of time during this market’s timeframe will suffice for a "Yes" resolution. The primary resolution source for this market will be the CDC’s official Travel Health Notices page (https://wwwnc.cdc.gov/travel/notices); however, a consensus of credible reporting will also be used.

Cuidado con los enlaces externos.

Preguntas frecuentes

"CDC issues Level 4 warning by December 31?" es un mercado de predicción en Polymarket donde los operadores compran y venden acciones de "Sí" o "No" según si creen que este evento ocurrirá. La probabilidad actual según la comunidad es 14% para "Yes". Por ejemplo, si "Sí" se cotiza a 14¢, el mercado colectivamente asigna una probabilidad de 14% de que este evento ocurra. Estas probabilidades cambian continuamente a medida que los operadores reaccionan a nuevos desarrollos e información. Las acciones del resultado correcto son canjeables por $1 cada una tras la resolución del mercado.

A día de hoy, "CDC issues Level 4 warning by December 31?" ha generado $72K en volumen total de trading desde que el mercado se lanzó el Jan 19, 2026. Este nivel de actividad refleja un fuerte compromiso de la comunidad de Polymarket y ayuda a garantizar que las probabilidades actuales estén respaldadas por un amplio grupo de participantes del mercado. Puedes seguir los movimientos de precios en vivo y operar en cualquier resultado directamente en esta página.

Para operar en "CDC issues Level 4 warning by December 31?", simplemente elige si crees que la respuesta es "Sí" o "No". Cada lado tiene un precio actual que refleja la probabilidad implícita del mercado. Introduce tu cantidad y haz clic en "Operar". Si compras acciones de "Sí" y el resultado se resuelve como "Sí", cada acción paga $1. Si se resuelve como "No", tus acciones de "Sí" pagan $0. También puedes vender tus acciones en cualquier momento antes de la resolución para asegurar ganancias o limitar pérdidas.

La probabilidad actual para "CDC issues Level 4 warning by December 31?" es 14% para "Yes". Esto significa que la comunidad de Polymarket actualmente cree que hay una probabilidad de 14% de que este evento ocurra. Estas probabilidades se actualizan en tiempo real basándose en operaciones reales, proporcionando una señal continuamente actualizada de lo que el mercado espera.

Las reglas de resolución para "CDC issues Level 4 warning by December 31?" definen exactamente qué debe ocurrir para que cada resultado sea declarado ganador, incluyendo las fuentes de datos oficiales utilizadas para determinar el resultado. Puedes revisar los criterios de resolución completos en la sección "Reglas" en esta página sobre los comentarios. Recomendamos leer las reglas cuidadosamente antes de operar, ya que especifican las condiciones exactas, casos especiales y fuentes.